title: Somatic and dendritic perforated-patch recordings reveal b-adrenergic receptor-induced depolarization in medial prefrontal cortex pyramidal neurons.
abstract: The aim of this perforated-patch study was to test the effect of isoproterenol on the membrane potential in mPFC (medial prefrontal cortex) pyramidal neurons. Isoproterenol depolarized the membrane potential recorded from the soma. This effect was absent in the presence of metoprolol, suggesting the involvement of beta1-adrenergic receptors. The adenylate cyclase activator forskolin also depolarized the membrane potential. Moreover, the effect of isoproterenol was abolished by the adenylate cyclase inhibitor SQ 22536. This suggested that adenylate cyclase was involved in mediating the effect of the beta-adrenergic receptor agonist. The isoproterenol-induced depolarization persisted after inhibition of protein kinase A with H-89. The effect of beta-adrenergic receptor activation on the membrane potential was dependent on Ih channels because it was abolished in the presence of the Ih channel inhibitor ZD 7288. Dendritic recordings were also performed. In the dendritic segments between 100 microm and 150 microm from the soma and between 200 microm and 250 microm from the soma, isoproterenol also depolarized the membrane potential. The magnitude of the beta-adrenergic receptor-stimulated depolarization was the same in the soma and in both dendritic localizations. The depolarization exerted by isoproterenol may influence PFC cognitive functions.
authors.affiliation: Department of Physiology and Pathophysiology, The Medical University of Warsaw, Warsaw, Poland, Department of Drug Technology and Pharmaceutical Biotechnology The Medical University of Warsaw, Warsaw, Poland. bartlomiej.szulczyk@wum.edu.pl.
authors.forename: Bartłomiej
authors.initials: B
authors.lastname: Szulczyk
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors / Q000494:pharmacology; D058671:Adrenergic beta-1 Receptor Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D001703:Biophysics; D001993:Bronchodilator Agents / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D003712:Dendrites / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004558:Electric Stimulation; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology*; D008790:Metoprolol / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D017397:Prefrontal Cortex / Q000166:cytology*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D017966:Pyramidal Cells / Q000166:cytology* / Q000187:drug effects*; D051381:Rats; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*; D026941:Sodium Channel Blockers / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
chemical_list: D000067956:Adenylyl Cyclase Inhibitors; D058671:Adrenergic beta-1 Receptor Antagonists; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D047428:Protein Kinase Inhibitors; D011943:Receptors, Adrenergic, beta; D026941:Sodium Channel Blockers; C017759:9-(tetrahydro-2-furyl)-adenine; D005576:Colforsin; D013779:Tetrodotoxin; D008790:Metoprolol; D000225:Adenine; D007545:Isoproterenol